as on October 24, 2025 at 11:57 am IST
Day's Low
Day's High
6.21%
Downside
1.26%
Upside
52 Week's Low
52 Week's High
78.71%
Downside
25.50%
Upside
as on October 24, 2025 at 11:57 am IST
Market Cap
₹14.88 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
0Return on capital employed (ROCE)
0Beta (LTM)
0.17
P/B Ratio
-22.63
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
300
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bullish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Venmax Drugs & Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 14.88 | 66.32% | 0.00 | -1 | NA | |
| NA | 13.00 | -3.25% | 0.00 | -3 | 28 | |
| NA | 254.12 | 16.64% | 0.63 | 4 | 196 | |
| BUY | 7,288.13 | -8.37% | 0.53 | 343 | 4,118 | |
| HOLD | 14,941.35 | -1.65% | 0.52 | 1,883 | 4,429 |
Search interest for Venmax Drugs & Pharmaceuticals Ltd Stock has increased by 1% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:1% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Venmax Drugs & Pharmaceuticals Ltd.
Venmax Drugs & Pharmaceuticals Ltd’s net profit jumped 300% since last year same period to ₹0.04Cr in the Q1 2025-2026. On a quarterly growth basis, Venmax Drugs & Pharmaceuticals Ltd has generated -94.87% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, Venmax Drugs stock has moved up by 11.6%
Best in 1 Year
![]()
In the last 1 year, Venmax Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 23.14% of holdings in Sep 2025 quarter
Retail Holding Down
![]()
Retail Investor have decreased holdings from 76.87% to 76.87% in Sep 2025 quarter
| Organisation | Venmax Drugs & Pharmaceuticals Ltd |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Venmax Drugs & Pharmaceuticals Ltd share price today stands at ₹29.45 as on . Venmax Drugs & Pharmaceuticals Ltd share today touched a day high of ₹29.82 and a low of ₹27.62.
Venmax Drugs & Pharmaceuticals Ltd touched a 52 week high of ₹36.96 and a 52 week low of ₹6.27. Venmax Drugs & Pharmaceuticals Ltd share price today i.e. is trending at ₹29.45, which is -20.32% down from its 52 week high and 369.70% up from its 52 week low.
Venmax Drugs & Pharmaceuticals Ltd market capitalisation is ₹14.88 Cr as on .
To buy Venmax Drugs & Pharmaceuticals Ltd shares, you need to follow these steps:
Venmax Drugs & Pharmaceuticals Ltd trading volume is 17.05K as on . This means that 17.05K shares of Venmax Drugs & Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.